30 Day Trial

About ORTHOWORLD

Founded in 1992, ORTHOWORLD® is the only provider of strategic intelligence in the world solely focused on the global orthopaedic market. Its singular mission is helping orthopaedic companies and individuals improve their performance.

Highly specialized product offerings such as ORTHOWORLD Membership, ORTHOFLASH®, market reports, ORTHOPRENEUR®, BONEZONE® and OMTEC® empower industry participants to respond to challenges, maximize opportunities and more aggressively expand their orthopaedic businesses. We welcome the opportunity to assist you.

ORTHOFLASH Subscribe

02/24/2017
  • 2:30 p.m. ORTHOWORLD estimates Integra LifeSciences’ 2016 orthopaedic revenue at US $108.3MM, +20.8% from 2015, with 4Q16 revenue of $26.7MM, -0.2% vs. 4Q15.
  • Exactech reported 2016 revenue of US $257.6MM, +6.5% from 2015, with 4Q16 revenue of $66.2MM, +5.6% vs. 4Q15.
  • 8:00 a.m. Paragon 28 launched PRESERVEHammerGraft™, aseptically-processed allograft implants for the treatment of hammertoe deformity.
Read More

Articles of Interest All Articles

DePuy Synthes' President Set to Lead AdvaMed's Orthopaedic Priorities of Registries, Payments

AdvaMed has identified developing an effective U.S. device registry and ensuring new payment methodologies capture the value of implants as two priorities for its orthopaedic sector. Juan-José Gonzalez, President, U.S. DePuy Synthes, was tapped to lead the sector.